Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program

Absztrakt
Leírás
Kulcsszavak
Forrás
Pathology & Oncology Research. -25 : 4 (2019), p. 1615-1620. -Pathol. Oncol. Res. - 1219-4956. - 1532-2807